China/Asia Attendees
01Life Technology — CBO
3D Medicines Inc. — VP & Board Secretary
4B Technologies — Global Head of Business Development
5Y Capital — Associate
Alphamab Oncology — BD Director
ApicHope Pharmaceutical — CSO
ApicHope Pharmaceutical — BD Director
Aptabio Therapeutics Inc. — Director, R&D and BD
Asahi Kasei Pharma Corporation — Manager
Asahi Kasei Pharma Corporation — Manager
Asymchem Zunji Capital — Senior Investment Manager
Sinotau Pharmaceutical Group — Co-founder & CEO
Beijing Zhaode Investment Group — Investment Associate
BioTrack Capital — Executive Director
Chengdu Brilliant Pharmaceutical — CEO
CMS Bio — Chief Business Officer
CMS Group — VP
Consun Pharmaceutical — Executive Director
CSPC Pharma — CMO
Daiichi Sankyo — Oncology Early-Stage Evaluation Lead
Dongbao Pharma — Operation Management General Manager
E Fund Management — Analyst
Excyte Biopharma — BD Director
Excyte Biopharma — Chairman, Co-founder, COO
Fast Track Initiative — Managing Partner
Fuji Pharma Co. Ltd. — General Manager – Business Development
Genesis Capital — Executive Director
Genhouse — CNO
Haisco Pharmaceutical — BD Director
Hansoh Pharmaceutical —
HEC — Overseas BD Director
HEC — CSO
HEC — Minister of Commerce
Hinova Pharmaceuticals Inc. — SVP
Hinova Pharmaceuticals Inc. — CSO
HK Inno.N — Head of K-CAB BD
HK Inno.N — BD
HK Inno.N — Vice President
HK Inno.N — Analyst
HK Inno.N — Manager
Huadong Medicine Co., Ltd. — GM, BD & Investment
Humanwell Healthcare (Group) Co. Ltd. — Director of Pharmacology
Humanwell Healthcare (Group) Co. Ltd. — Senior Director of Business Development
IASO Bio — BD
Ieum value creator, Inc. — Principal Consultant
Ildong Pharmaceutical — Business Development Manager
Ildong Pharmaceutical — Head of BD&L, Managing Director
Kaken Pharmaceutical — BD, Lead of Transactions
Kaken Pharmaceutical — Manager, Business Development
Maruho Co Ltd — Group Manager
Metis TechBio — BD Team, North America
Novo Holdings — Partner
NRT — AD of BD
Oriza Seed — Investment Director
Pin Therapeutics — Founder & CEO
Pivotal bioVenture Partners — Director
Qilu Pharmaceutical — BD Director
Ranok Therapeutics — CFO
Santen — US BD Manager
Santen — Vice President, Global Regulatory Affairs
Santen — Director, Venture Management
Shanghai Healthcare Capital — Senior Manager
Shenzhen CrystalO Biopharma — VP, BD Head
Sihuan Pharmaceutical — Deputy CEO / CFO, Executive Director
Simcere Pharmaceuticals — SVP
Sino Biopharma — BD Director
SK Biopharmaceuticals — Director BD
SPH Biotherapeutics (HK) Limited — VP and CSO
Ubix Therapeutics — Director of Business Development
VelaVigo — CBO/CFO
Viva BioInnovator — Chief Innovation Officer, Head of Investment
VMS — Partner
WUHAN BINHUI BIOPHARMACEUTICAL CO., LTD — President and CEO
Xuanzhu Biopharmaceutical — Senior Director of Business Development
Yan Feng — CEO
Yifan Pharmaceutical — BD Head
Youcare Pharmaceutical — BD Head
US/EU/Other Regions Attendees
AbbVie — Director, BD & Acquisitions
AdBio partners — EiR
Aditum Bio — Senior Associate
Advantary Capital Partners — Partner
Amplitude Ventures — Principal
Apellis Pharmaceuticals — Chief Business & Strategy Officer
Apeximmune Therapeutics Inc. — CEO
Arbor Biotechnologies — BD
Architect Therapeutics / ARCH Venture — Corporate Development
ArriVent Bio — BD Director
Aureka Biotechnologies — CEO
Bain Capital — Vice President
BioAge Labs — Director, Business Development
Biobloc — CEO
BioNTech — Senior Director of External Innovations
Boehringer Ingelheim CHB — Head of Eye Health & Research Beyond Borders
Boehringer Ingelheim International GmbH — Global Head of Neuroscience & Mental Health BD+L
Bonum Therapeutics — VP Development
Brii Biosciences — Sr Director, Business Development and Alliance Management
Bristol Myers Squibb — Associate Director, BD Search & Evaluation
chipscreen Bioscience (US) Ltd — GM
Crinetics Pharmaceuticals — Business Development Manager
Cytokinetics — Senior Director Business Development
Debiopharm — Head of Strategic Partnering
Decheng Capital — Investor
Deerfield Management — Investor
Fairmount Funds — Operating Partner
Forbion — Principal
Formation Bio — Senior Director
Gilead Sciences — Senior Scientist
GSK — Executive Director, Business Development Transactions
Helsinn — Chief Strategy Officer
Helsinn — BD & Licensing-Out Director
HUYABIO International — China Operations Manager
IKSUDA Therapeutics — CBO
Indaco Venture Partners — Partner, Biotech Fund
Insmed — Associate Director BD
Insmed — VP, Head of BD
Iterion Therapeutics — President & CEO
Johnson & Johnson — External Scientific Innovation, Transactions
Johnson and Johnson — Senior Director, Immunology External Innovation
Kolon TissueGene — CCO
Kolon TissueGene — Director, Commercial Strategy and Partnership
KPMG — SMD Tax
Kymera Therapeutics — Director, Business Development
Legend Biotech — Executive Director, Business Development
LIFTT — Venture Capital Manager
LRI — VP
LSVP — Head of Biotech
Lumira Ventures — Partner
LYFE Capital — Senior Associate
LYFE Capital — Director of Global Partnership
LYFE Capital — Partner
Medicilon — Director, BD
Medicilon — VP of Global BD
MP Healthcare Venture Management — President
MP Healthcare Venture Management — Director
NiKang Therapeutics — President & CEO
NMS — CFO
Normunity — Head of BD
OrbiMed — Partner
Pfizer — Global Development Lead
PROMOMED LLC — Director for New Products
PROMOMED LLC — Chairman of the Board
RA Capital — Senior Research Assistant
Roche — Senior Director
Roche / Genentech — Global Search and Evaluation Lead
RTW Investments — VP, New Ventures
Salubris Biotherapeutics — CMO
Salubris Biotherapeutics — Chief Executive Officer
SaniMed Science Group — Founder & CEO
Servier — Head of External Innovation
Sobi — Head of Search and Evaluation
Swedish Orphan Biovitrum (Sobi) — Strategy & Corporate Development
Swedish Orphan Biovitrum (Sobi) — Head of Search and Evaluation
SymBiosis Capital Management — Vice President of Investments
Taiho Ventures — Partner
The Venture Collective, LLC — Head of Life Science Investing
Verdiva Bio — Chief Strategy Officer
Vibrant Therapeutics — Head of BD
Viridian Therapeutics — Executive Director, Business Development & Alliances
Viridian Therapeutics — Director, BD & Alliances
Virion Therapeutics LLC — COO
Yonjin Venture — Investment Manager
BioToChina.org 